| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

Department of Molecular Genetics, The Weizmann Institute of Science, Rehovot 76100, Israel
Received 9 November 2006/ Returned for modification 26 December 2006/ Accepted 7 August 2007
Protein tyrosine phosphatases (PTPs) are key mediators that link physiological cues with reversible changes in protein structure and function; nevertheless, significant details concerning their regulation in vivo remain unknown. We demonstrate that PTP
associates with microtubules in vivo and is inhibited by them in a noncompetitive manner. Microtubule-associated proteins, which interact strongly with microtubules in vivo, significantly increase binding of PTP
to tubulin in vitro and further reduce phosphatase activity. Conversely, disruption of microtubule structures in cells reduces their association with PTP
, alters the subcellular localization of the phosphatase, and increases its specific activity. Activation of the epidermal growth factor receptor (EGFR) increases the PTP
-microtubule association in a manner dependent upon EGFR-induced phosphorylation of PTP
at Y638 and upon microtubule integrity. These events are transient and occur with rapid kinetics similar to EGFR autophosphorylation, suggesting that activation of the EGFR transiently down-regulates PTP
activity near the receptor by promoting the PTP
-microtubule association. Tubulin also inhibits the tyrosine phosphatase PTP1B but not receptor-type PTPµ or the unrelated alkaline phosphatase. The data suggest that reversible association with microtubules is a novel, physiologically regulated mechanism for regulation of tyrosine phosphatase activity in cells.
Published ahead of print on 20 August 2007.
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|